Impact BioMedical, Inc.

IBOAMEX • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
0.44 USD
↘ 0.02 (4.37%)AT CLOSE (11:59 AM EDT)
0.46
↗ 0.02 (3.61%)
POST MARKET (AS OF 07:56 PM EDT)
Post Market
AS OF 07:56 PM EDT
0.46
↗ 0.02 (3.61%)
🔴Market: CLOSED

Impact BioMedical, Inc. (IBO) trades at $0.44 per share. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, IBO is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Aug 26, 2026.

Open?$0.45
High?$0.49
Low?$0.44
Prev. Close?$0.46
Volume?13.1K
Avg. Volume?30.0K
VWAP?$0.46
Rel. Volume?0.44x
Bid / Ask
Bid?$0.44 × 1.8K
Ask?$0.49 × 400
Spread?$0.05
Midpoint?$0.46
Valuation & Ratios
Market Cap?47.4M
Shares Out?107.8M
Float?11.7M
Float %?10.9%
P/E Ratio?60.13
P/B Ratio?4.41
EPS?$0.01
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Themes
Biotech - Drug Development›Neuroscience & CNSHealthcare - Oncology›Immunotherapy & Immuno-OncologyBiotech - Drug Development›Infectious Disease & Vaccines
Employees
8
Market Cap
49.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.impactbiomedinc.com
Listed
2024-09-16
Address
1400 BROADFIELD BLVD.
HOUSTON, TX 77084
Phone: 585 232 1500
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
98
Momentum?
71
Short Sent.?
36
Piotroski F-Score?0/9Weak
Altman Z-Score?4.90Safe
Confidence?40%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?4.66%Low
Short Interest?546.7K
Days to Cover?13.2
Free Float11.7M
Avg Daily Volume41.4K
Settlement Date2026-08-14
Financial Health
Current Ratio?0.16Weak
Quick Ratio?0.13Weak
Cash Ratio?0.00Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
53/100
P/E?
Peers
100
S&P
9
60.1PRICEY▾
P/B?
Peers
100
S&P
41
4.41FAIR▾
P/S?
Peers
100
S&P
3
1,355.47HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-12.0CHEAP▾
EV/Sales?
Peers
100
S&P
3
1,355.18HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
24
7.3%FAIR▾
ROA?
Peers
50
S&P
43
4.7%FAIR▾
Cash Flow & Enterprise
FCF?$-508000
Enterprise Value?$47.4M
Fundamentals ratios updated end of day
MarketsMoversWatchlist